Glioblastoma, head and neck squamous cell carcinoma, esophagogastric adenocarcinoma and non-small cell lung cancer were the top four tumors with the highest alteration frequencies of LANCL2 and EGFR (Fig. 1A, B). The gene discussed is EGFR; the disease is gastroesophageal junction adenocarcinoma.